Amplify Treatments, Testing And Advancements ETF NVAX Holdings History
Amplify Treatments, Testing and Advancements ETF's Novavax Inc Holding Summary
As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 20,011.00 shares of Novavax Inc(NVAX), totaling $253,340.00. This investment constitutes 2.77% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0.01% of the outstanding Novavax Inc(NVAX) stock.
The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $10.06 for 16,005.00 shares. Based on historical transaction data and NVAX's current price of $7.22, Amplify Treatments, Testing and Advancements ETF's estimated gain on his NVAX holdings is $138,375.48, reflecting a 82.80% gain to date.
Amplify Treatments, Testing and Advancements ETF NVAX ($7.22) Holding Chart
Amplify Treatments, Testing and Advancements ETF NVAX ($7.22) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
